Delivery Order SPE2DB22D9112-SPE2DB25FTKPL
- Not listed
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order valued at $12,191.59 by the Defense Logistics Agency on May 30, 2025, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, which carries an ultimate completion date of June 2, 2025, was issued without a set-aside designation. The award leverages DMS Pharmaceutical Group's position as a critical supplier within...
- The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was selected as the awardee under a firm fixed-price contract type. The delivery order carries an ultimate completion date of July 11, 2025, with performance to be executed at the vendor's Park Ridge location. No...
- The Defense Logistics Agency issued a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). This firm fixed-price delivery order, valued at $12,146.79, was awarded on July 29, 2025, with an ultimate completion date of July 30, 2025. The award carries no set-aside designation, reflecting DMS Pharmaceutical Group's competitive standing as a small business in...
- The Defense Logistics Agency awarded a delivery order valued at $12,089.78 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Jakafi 20 mg tablets (60-count units). This firm fixed-price delivery order, issued on August 6, 2025, is due for completion by August 7, 2025, and carries no set-aside designation. DMS Pharmaceutical Group is performing under its larger Indefinite Delivery Contract with the DLA...
- The Defense Logistics Agency awarded a delivery order valued at $12,115.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This firm fixed-price delivery order, issued on June 18, 2025, with an ultimate completion date of June 20, 2025, represents a direct pharmaceutical supply transaction under DMS's existing Indefinite Delivery Contract with the Defense Logistics...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a firm fixed-price delivery order valued at $24,293.60 to DMS Pharmaceutical Group Inc. for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, was selected without a set-aside designation. The delivery order is scheduled for completion by June 18, 2025, and represents performance of work at the...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc. on September 2, 2025, for the supply of Jakafi 5 mg tablets (60 count) with a contract value of $24,293.60. This firm fixed-price delivery order, with an ultimate completion date of September 3, 2025, represents a fulfillment under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with DLA valued at $499.999 billion and valid through November 2026. The award was made without a set-aside...
- The Defense Logistics Agency awarded a delivery order valued at approximately $12.1K to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 5 mg tablets (60-count units). The contract carries a firm fixed-price structure with no set-aside designation and an ultimate completion date of July 31, 2025. This delivery order was issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count). This firm fixed-price delivery order, valued at $12,115.65, was awarded on August 7, 2025, with an ultimate completion date of August 8, 2025. The contract carries no set-aside designation. DMS Pharmaceutical Group is performing the work at its Park Ridge, Illinois...
- The Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Jakafi 10 mg tablets (60-count units). This $12,115.65 firm fixed-price delivery order was awarded on July 14, 2025, with an ultimate completion date of July 15, 2025, and is not designated as a set-aside contract. The delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery...
- SPE2DB22D9112Indefinite Delivery Contract
- SPE2DB22D9112-SPE2DB25FTKPLDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $12,146.79 to DMS Pharmaceutical Group Inc. on August 4, 2025, for the supply of Jakafi 5 mg tablets (60-count units). DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, will perform this delivery order at its Park Ridge facility. This award utilizes a firm fixed-price contract structure with no set-aside designation, allowing the vendor to compete directly in the federal marketplace based on its small business status. This delivery order is issued under DMS Pharmaceutical Group's larger Indefinite Delivery Contract with the Defense Logistics Agency valued at $499,999,999 and extending through November 2026. The indefinite delivery vehicle enables the agency to procure a comprehensive range of pharmaceutical products, including branded and generic prescription drugs, biologics, and medical consumables to support Department of Defense healthcare facilities nationwide. As a critical supplier in the federal pharmaceutical supply chain since 2001, DMS Pharmaceutical Group has established a robust portfolio of delivery orders across diverse medical products, positioning it as a key distributor for military health system requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $12.1k | 8/4/25 |